Correlation Between Seres Therapeutics and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Immix Biopharma, you can compare the effects of market volatilities on Seres Therapeutics and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Immix Biopharma.
Diversification Opportunities for Seres Therapeutics and Immix Biopharma
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Seres and Immix is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Immix Biopharma go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Immix Biopharma
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.39 times less return on investment than Immix Biopharma. In addition to that, Seres Therapeutics is 1.26 times more volatile than Immix Biopharma. It trades about 0.12 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.2 per unit of volatility. If you would invest 158.00 in Immix Biopharma on September 4, 2024 and sell it today you would earn a total of 43.00 from holding Immix Biopharma or generate 27.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Immix Biopharma
Performance |
| Timeline |
| Seres Therapeutics |
| Immix Biopharma |
Seres Therapeutics and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Immix Biopharma
The main advantage of trading using opposite Seres Therapeutics and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Seres Therapeutics vs. Candel Therapeutics | Seres Therapeutics vs. Cingulate Warrants | Seres Therapeutics vs. Unicycive Therapeutics | Seres Therapeutics vs. Quoin Pharmaceuticals Ltd |
| Immix Biopharma vs. Candel Therapeutics | Immix Biopharma vs. Cingulate Warrants | Immix Biopharma vs. Unicycive Therapeutics | Immix Biopharma vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |